Results 101 to 110 of about 204,995 (239)

Esophageal carcinoma

The Journal of Thoracic and Cardiovascular Surgery, 1994
Michael D. Lieberman, Dido Franceschi, Benjamin Marsan, Michael Burt   +3 more
openaire   +1 more source

Immunotherapy in advanced gastroesophageal cancers: A meta‐analysis of sex‐based outcomes in overall survival

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) improve survival in advanced gastroesophageal cancer (GEC), but their benefits may differ by sex. Little is known, however about the impact of sex‐related immune differences on ICI efficacy. In this meta‐analysis, sex‐specific outcomes of ICI therapy were evaluated in advanced GEC, encompassing both ...
Michael Masetti, Fausto Petrelli, Filippo Pietrantonio, Sylvie Lorenzen, Alberto Giovanni Leone   +4 more
wiley   +1 more source

An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. [PDF]

J Immunother Cancer
Wan L, Li B, Ma T, Wang M, Xie F, Ge H, Xiao Z, Chen X, Meng L, Zhang L, Xie K, Wang Q.   +11 more
europepmc   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source

[Expression of Concern] Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression. [PDF]

Int J Oncol
Yang XX, Ma M, Sang MX, Wang XX, Song H, Liu ZK, Zhu SC.   +6 more
europepmc   +1 more source

Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort

Interdisciplinary Medicine, EarlyView.
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li, Shun Wang, Guowei Zhao, Jiangtao Li, Xin Li, Bingning Wang, Yi Zhang, Mengfei Yao, Lei Guo, Jianming Ying, Wenbin Li   +10 more
wiley   +1 more source

Aging-associated mechanisms and metabolic vulnerabilities in esophageal carcinoma: an integrative review. [PDF]

Front Cell Dev Biol
Liu Q, Xie Z, Li W, Li M, Qi Y.
europepmc   +1 more source

Gut microbiome‐derived metabolites show promise in cancer research and therapy

Interdisciplinary Medicine, EarlyView.
The metabolites produced by the gut microbiome, which are subject to regulation by multiple factors, play a pivotal role in the progression of various types of cancer. These metabolites not only function as potential biomarkers for the early detection and monitoring of tumor development, but also actively participate in cancer therapeutic processes ...
Kangjie Yang, Yifan Wang, Daolin Tang, Peilong Li, Lutao Du   +4 more
wiley   +1 more source

Comprehensive Analysis of the Prognostic Significance of ZHX Family Members in Esophageal Carcinoma. [PDF]

Int J Gen Med
You Y, Li W, Ma Y, Gao L, Li T, Zhang X, Luo X.   +6 more
europepmc   +1 more source

Esophageal Carcinoma [PDF]

, 2020
openaire   +1 more source